P-Xylene

P-Xylene

SCHEMBL6536586

CCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCC.Cc1ccc(C)cc1

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.75
DNM1 Q05193 1/20 0.57
PAM P19021 2/20 0.53
TSHR P16473 1/20 0.50
MAPT P10636 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
LMNA P02545 2/20 0.49
ALDH1A1 P00352 1/20 0.49
NAAA Q02083 1/20 0.48
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HTR2C P28335 1/20 0.47
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46
MGLL Q99685 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Xylene SCHEMBL15988059 1.00 DGKA (0.75) DGKADNM1PAMTSHRMAPT
Ethylene Glycol Dioctanoate SCHEMBL15987600 1.00 DGKA (0.75) DGKADNM1PAMTSHRMAPT
P-Xylene SCHEMBL15987620 1.00 DGKA (0.75) DGKADNM1PAMTSHRMAPT
P-Xylene SCHEMBL15987887 1.00 DGKA (0.75) DGKADNM1PAMTSHRMAPT
SCHEMBL12768699 0.89 DGKA (0.59) DGKATSHRPRSS1PRSS2PRSS3
SCHEMBL13933190 0.89 DGKA (0.59) DGKATSHRPRSS1PRSS2PRSS3
SCHEMBL13612295 0.89 DGKA (0.59) DGKATSHRPRSS1PRSS2PRSS3
SCHEMBL13854770 0.87 DGKA (0.57) DGKATSHRLMNAALDH1A1MEN1
P-Xylene SCHEMBL9305936 0.87 DGKA (0.56) DGKADNM1PAMPRSS1PRSS2
SCHEMBL813087 0.87 DGKA (1.00) DGKADNM1PAMTSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2772523-B1 REVERSIBLY THERMOCHROMIC COMPOSITION PILOT CORPORATION KK (JP) 2018-11-28 EP disclosed
US-20140291585-A1 REVERSIBLY THERMOCHROMIC COMPOSITION KABUSHIKI KAISHA PILOT CORPORATION (JP) 2014-10-02 US disclosed
EP-2772523-A1 REVERSIBLY THERMOCHROMIC COMPOSITION Kabushiki Kaisha Pilot Corporation (JP) 2014-09-03 EP disclosed
US-6828070-B2 Heat sensitive element FUJI PHOTO FILM CO., LTD. (JP) 2004-12-07 US disclosed
US-6790809-B2 HEAT-RESPONSIVE-DISCOLORING COLORING COMPOSITION EASILY DECOLORED BY DRY TREATMENT, AND WHICH DOES NOT RECOVER COLOR ONCE DISCOLORED, EVEN WHEN ITS TEMPERATURE IS LOWERED TO TEMPERATURE LOWER THAN DISCOLORATION INITIATION TEMPERATURE FUJI PHOTO FILM CO., LTD. (JP) 2004-09-14 US disclosed
US-6746830-B2 CAPABLE OF RAPIDLY FORMING HIGH-QUALITY IMAGE EXCELLENT IN SHARPNESS, COLOR REPRODUCIBILITY AND OPTICAL READABILITY FUJI PHOTO FILM CO., LTD. (JP) 2004-06-08 US disclosed
US-20040006096-A1 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels CELGENE CORPORATION 2004-01-08 US disclosed
US-6656964-B2 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases CELGENE CORPORATION 2003-12-02 US disclosed
US-20030186176-A1 Silver halide photosensitive material and image-forming method using heat-responsive-discolorable coloring composition FUJI PHOTO FILM CO., LTD. 2003-10-02 US disclosed
US-20030064890-A1 Heat-responsive-discoloring coloring composition, heat-responsive-discoloring coloring element comprising same and method for detecting thermal history of article FUJI PHOTO FILM CO., LTD. 2003-04-03 US disclosed
US-20020015903-A1 Photosensitive material comprising reversibly decolorable colored layer and image-forming method using same FUJI PHOTO FILM CO., LTD. 2002-02-07 US disclosed
US-20010049371-A1 Method of inhibiting phosphodiesterases with substituted alkanohydroxamic acids CALGENE CORPORATION 2001-12-06 US disclosed
US-6214857-B1 REDUCES TUMOR NECROSIS FACTOR LEVELS CELGENE CORPORATION 2001-04-10 US disclosed
EP-0677564-B1 Opaque/transparent thermochromic compositions and laminate PILOT INK CO LTD (JP) 1999-05-12 EP disclosed
EP-0827843-A1 Temperature-dependent color/transparency storing resin composition and laminate member employing the same THE PILOT INK CO., LTD. (JP) 1998-03-11 EP disclosed
US-5721059-A THERMOCHROMIC BLENDS COMPRISING AN ELECTRON-DONATING COLOR DYES, A PHENOLIC HYDROXY RADICAL AND A COMPOUND SELECTED FROM ALCOHOLS, ESTERS, KETONES AND CARBOXYLIC ACIDS IN VINYL ACETATE-VINYL CHLORIDE COPOLYMER; TOYS, COMPUTERS, OPTICS THE PILOT INK CO., LTD. (JP) 1998-02-24 US disclosed
US-5585425-A Thermochromic opaque/transparent composition, laminate member employing the same, and three-dimensional member employing said laminate member and capable of concealing and revealing the interior THE PILOT INK CO., LTD. (JP) 1996-12-17 US disclosed
US-5490956-A Thermochromic opaque composition, laminate member employing the same, and three-dimensional member employing said laminate member and capable of concealing and revealing the interior PILOT INK CO., LTD. (JP) 1996-02-13 US disclosed
EP-0677564-A2 Opaque/transparent thermochromic compositions and laminate THE PILOT INK CO., LTD. (JP) 1995-10-18 EP disclosed
EP-0595577-A2 Thermochromic opaque composition and uses thereof THE PILOT INK CO., LTD. (JP) 1994-05-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006096-A1 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels TNF, TNFRSF1A, LTA DGKA 1648/4885DNM1 4187/4885PAM 930/4885
US-20010049371-A1 Method of inhibiting phosphodiesterases with substituted alkanohydroxamic acids PDE3A, PDE2A, PDE3B DGKA 1626/4885DNM1 3759/4885PAM 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.